Internal Medicine, Medical Oncology · Webster, TX
NPI
1164464152
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
501 W Medical Center Blvd
Webster, TX, 77598
Phone (281) 332-7505
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.0M
73,376 services
Medicare patients, 2024
441
Average age 76
Drug cost, 2024
$2.4M
945 prescriptions
Company payments, 2025
$1,300
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Khalid Mahmood was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 16,320 times for 22 patients. In total Khalid Mahmood billed 73,376 services in 128 codes, and Medicare paid $1.0M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-09-25.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 16,320 | 22 | $0.28 | $4,595 |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 6,100 | 44 | $0.10 | $628 |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2,745 | 13 | $2.21 | $6,057 |
| 36415 Venipuncture Blood Collection | Office | 929 | 216 | $8.64 | $8,028 |
| 85025 Blood Count | Office | 900 | 221 | $7.55 | $6,791 |
| 80053 Clinical Chemistry | Office | 683 | 191 | $10.32 | $7,049 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 439 | 192 | $12.88 | $5,653 |
| 99214 Office E&M - Established | Office | 437 | 168 | $95.07 | $42K |
| 99233 Hospital E&M - Subsequent | Facility | 369 | 76 | $93.98 | $35K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 340 | 16 | $0.09 | $30.35 |
| 99213 Office E&M - Established | Office | 270 | 148 | $61.92 | $17K |
| 82728 Clinical Chemistry | Office | 249 | 95 | $13.27 | $3,304 |
| 83540 Clinical Chemistry | Office | 248 | 95 | $6.30 | $1,562 |
| 83550 Clinical Chemistry | Office | 248 | 95 | $8.51 | $2,111 |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 137 | 14 | $73.96 | $10K |
By year: 2022 $671K for 75,206 services; 2023 $628K for 65,911 services; 2024 $1.0M for 73,376 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 929 | 216 | $8.64 | $8,028 |
| 85025 Blood Count | 900 | 221 | $7.55 | $6,791 |
| 80053 Clinical Chemistry | 683 | 191 | $10.32 | $7,049 |
| 82728 Clinical Chemistry | 249 | 95 | $13.27 | $3,304 |
| 83540 Clinical Chemistry | 248 | 95 | $6.30 | $1,562 |
| 83550 Clinical Chemistry | 248 | 95 | $8.51 | $2,111 |
| 85055 Blood Count | 84 | 38 | $35.03 | $2,943 |
| 83615 Clinical Chemistry | 39 | 27 | $5.80 | $226 |
| 85007 Blood Count | 22 | 11 | $3.72 | $81.84 |
| 85027 Blood Count | 22 | 11 | $6.34 | $139 |
Medicare prescription drug claims, 2024
In 2024, the drug Khalid Mahmood prescribed most often to Medicare patients was Eliquis (Apixaban), with 72 prescriptions and refills. In total Khalid Mahmood wrote 945 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 72 | 100 | 16 | $56K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 63 | 63 | 16 | $1,321 |
| Gabapentin Generic | 56 | 80 | 14 | $800 |
| Anastrozole Generic | 51 | 118 | 12 | $756 |
| Dexamethasone Generic | 47 | 49 | 11 | $432 |
| Revlimid Lenalidomide | 38 | 38 | Under 11 | $651K |
| Ondansetron Hcl Generic | 33 | 33 | 16 | $316 |
| Lorazepam Generic | 31 | 31 | Under 11 | $60.4 |
| Warfarin Sodium Generic | 31 | 72 | Under 11 | $204 |
| Potassium Chloride Generic | 29 | 45 | 14 | $422 |
| Verzenio Abemaciclib | 25 | 25 | Under 11 | $188K |
| Levothyroxine Sodium Generic | 24 | 37 | Under 11 | $186 |
| Olanzapine Generic | 22 | 22 | Under 11 | $254 |
| Acyclovir Generic | 21 | 29 | Under 11 | $243 |
| Xarelto Rivaroxaban | 20 | 60 | Under 11 | $32K |
Brand drugs: 258 claims; generic drugs: 687 claims; opioid claims: 99.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Khalid Mahmood $1,300 ($1,300 in general payments such as food, travel and fees) from 33 companies. The largest payer was Novartis Pharmaceuticals Corporation with $134.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 5 | $134 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $112 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $108 |
| Incyte Corporation INCY | 3 | $63.34 |
| Daiichi Sankyo Inc. 4568.T | 2 | $58.29 |
| Merck Sharp & Dohme LLC MRK | 2 | $54.36 |
| Genentech USA, Inc. ROG.SW | 3 | $53.45 |
| Adc Therapeutics America, Inc. | 2 | $52.88 |
| Janssen Biotech, Inc. JNJ | 2 | $44.68 |
| Abbvie Inc. ABBV | 2 | $43.27 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.